다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Lixte Biotechnology Holdings Inc (LIXT)
Lixte Biotechnology Holdings Inc (LIXT) 뉴스

LIXT

Lixte Biotechnology (LIXT)

Lixte Biotechnology Holdings Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LIXT

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/08	22:25	GlobeNewswire Inc.	LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activation in Cancer”	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/04/25	04:25	AllPennyStocks.com	Mixed Shelf Filing Gives Micro Cap Delayed Boost	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/03/28	04:35	AllPennyStocks.com	Biotech Steals The Show Following Pre-Clinical Data Announcement	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/03/27	21:30	GlobeNewswire Inc.	NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD CLINICAL COMPOUND, CAN FORCE CANCER CELLS TO GIVE UP THEIR CANCER-CAUSING PROPERTIES	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/03/21	21:30	GlobeNewswire Inc.	LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy Cancer Treatments	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/02/28	06:59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/02/27	22:30	GlobeNewswire Inc.	Professor René Bernards to Present New Pre-Clinical Data on LIXTE’s LB-100 at Joint Conference of European and American Associations for Cancer Research	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/02/27	00:48	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/02/26	22:30	GlobeNewswire Inc.	LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/01/29	22:30	GlobeNewswire Inc.	First Patient Dosed with LIXTE’s LB-100 and GSK’s Immunotherapy Dostarlimab-gxly in Ovarian Clear Cell Carcinoma Trial	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/11/29	07:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/11/14	04:28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/11/13	22:30	GlobeNewswire Inc.	LIXTE Biotechnology Provides Update on Clinical Progress and Expanding Collaborations	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/11/10	07:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/10/18	06:27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/10/17	03:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/10/16	21:30	GlobeNewswire Inc.	LIXTE, Netherlands Cancer Institute, and Oncode Institute to Expand Collaboration	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/10/11	04:55	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/10/11	04:47	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/10/09	21:30	GlobeNewswire Inc.	LIXTE Biotechnology Holdings Announces the Passing of its Founder, John S. Kovach	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/10/06	09:39	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/10/06	09:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/10/05	07:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/09/30	05:05	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/09/27	19:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/09/27	19:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/09/26	21:30	GlobeNewswire Inc.	LIXTE Appoints Bas van der Baan as President and Chief Executive Officer	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/09/21	00:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/09/20	21:30	GlobeNewswire Inc.	LIXTE Biotechnology Announces a Supported Collaborative Trial to Study LIXTE’s First-in-Class PP2A Inhibitor, LB-100, Plus GSK’s Immunotherapy, Dostarlimab, in Clear-Cell Ovarian Cancer	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/08/22	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc

검색 관련기사 보기:NASDAQ:LIXT

1 2 3 4 5 6 7 다음 >>

Eagle Point Income

OMX Stockholm Investment...

Legolas LGO Token

Franklin Moderate Alloca...

NLBNPIT21EN4 20240920 31...

European Investment Bank

Franklin US Equity Index...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관